J 2015

Various forms of F-18-FDG PET and PET/CT findings in patients with polymyalgia rheumatica

ŘEHÁK, Zdeněk, Jiří VAŠINA, Petr NĚMEC, Zdeněk FOJTÍK, Renata KOUKALOVÁ et. al.

Basic information

Original name

Various forms of F-18-FDG PET and PET/CT findings in patients with polymyalgia rheumatica

Authors

ŘEHÁK, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), Jiří VAŠINA (203 Czech Republic, belonging to the institution), Petr NĚMEC (203 Czech Republic, belonging to the institution), Zdeněk FOJTÍK (203 Czech Republic, belonging to the institution), Renata KOUKALOVÁ (203 Czech Republic), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution), Dorota REHAKOVA (203 Czech Republic), Jan ADAM (203 Czech Republic), Alena VAVRUSOVA (203 Czech Republic) and Zdeněk ADAM (203 Czech Republic, belonging to the institution)

Edition

Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Palacký University, 2015, 1213-8118

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 0.924

RIV identification code

RIV/00216224:14110/15:00083435

Organization unit

Faculty of Medicine

UT WoS

000366566700018

Keywords in English

FDG; PET; PET/CT; polymyalgia rheumatica; bursitis; vasculitis; synovitis; giant cell arteritis

Tags

Tags

International impact, Reviewed
Změněno: 29/11/2016 15:00, Soňa Böhmová

Abstract

V originále

PMR presents by articular/periarticular synovitis, extraarticular synovitis and can be accompanied by giant cell arteritis. All types of involvement have their distinct FDG PET (PET/CT) finding, which can be seen either individually or in any of their 4 combinations. FDG PET (PET/CT) examination seems to be an advantageous one-step examination for detecting different variants of PMR, for assessing extent and severity and also for excluding occult malignancy.